Feeds:
Posts
Comments

Posts Tagged ‘chantix’

chantix (10/1, Boyles) reported that, according to a study published Oct. 1 in BMJ Online First, the risk of “suicide and suicidal thoughts” associated with the antismoking medication Chantix (varenicline) may “be very small.” British researchers “compared the incidence of suicide and self-harm among smokers taking Chantix to that of smokers using…Zyban [bupropion] or nicotine-replacement products to help them” stop smoking. Investigators then “identified 80,660 adults who were prescribed smoking-cessation products between Sept. 2006 and May 2008.” After using “electronic medical records” to search “for evidence of fatal and non-fatal self-harm, suicidal thoughts, and depression over the period in which the treatments were used up until three months after the last prescription was filled,” the team “found no clear evidence of an increased risk of self-harm, suicidal thoughts, or depression in Chantix users or users of any of the other products.”

Read Full Post »

Time (3/8, Cloud) reported that, according to a study published in the journal Biological Psychiatry, Chantix (varenicline) “has…helped a group of regular drinkers consume less alcohol.” For the study, conducted by researchers at Yale University, “twenty regular drinkers (defined as those who consume at least one drink per day and, at least once a week, three or more drinks in a single sitting) took varenicline or a placebo daily for a week before showing up for the experiment.” None of the subjects “was dependent on alcohol, and none had tested positive for illicit drugs.” At approximately “3 p.m. on the day of the experiment, all were asked to drink a cocktail of their choosing. Afterward, if they wanted, they could have more cocktails.” The researchers found that “the 10 who had taken varenicline drank an average of just .5 drinks after their first cocktail. By contrast, the 10 who were taking placebos consumed 2.6 drinks.”

Read Full Post »